{
  "docId": "019dd923-5fec-763b-95ce-df36eb136cb7",
  "docSlug": "v2M0U9ih51yxmXlSsD1M",
  "documentTitle": "See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad",
  "authorId": "Pitchdecks",
  "authorName": "Beckley Psytech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 9,
  "pageCount": 22,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": [
    "action_title",
    "bullet_list",
    "other"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95ce-df36eb136cb7/9",
  "deckHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95ce-df36eb136cb7#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.05,
        "y": 0.28
      },
      "kind": "image",
      "text": "Epidiolex",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "010a873c-6f6b-4aa0-b496-90547e5c6287",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.28
      },
      "kind": "image",
      "text": "Spravato",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8a061a73-499d-4d6d-861e-af9ab35ca527",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "GW Pharma cannabis-based pharmaceutical for rare pediatric epilepsy. FDA approved. $2bn peak sales forecast.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88b72697-a61f-4cbb-884c-8aa2d819bdaa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.55
      },
      "kind": "list",
      "text": "Johnson & Johnson ketamine-derivative pharmaceutical for treatment-resistant depression. FDA approved. $1.35bn peak sales forecast.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea421beb-3682-40c0-9e1f-d0df45a10a05",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "peak sales forecast: $2bn",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-d526-758a-9c8c-5e44eb0975a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "The Opportunity: Psychoactive and naturally-derived drugs are proving to be effective pharmaceutical medicines",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d564ab6f-3cc3-4169-97b3-9353b0422488",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "876d825a-e40d-4efb-81b2-68c87b331324",
      "evidence": "Citing FDA-approved drugs as proof of market viability",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 11,
      "from": 9,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "73496664-182b-4790-bfd4-11bd301d81a0",
      "evidence": "The deck highlights macroeconomic drivers and the current opportunity on pages 9-11",
      "position": 0,
      "objective": "Why now is the right time for psychedelic drug development",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.7,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}